Inventor · disambiguated record
Sanjeev Kumar
Also filed as: KUMAR SANJEEV
24 granted patents·6 pending applications·191 citations·filing 2003–2023
95Inventor score
Files withNEWLINK GENETICS CORP10GENENTECH INC3WANG SHAOMENG3ACERAND THERAPEUTICS USA LTD2MAUTINO MARIO R2
Top patents by PatentIndex Score
30 records- 0197US7759383B2Small molecule inhibitors of MDM2 and the uses thereofUNIV MICHIGAN·Filed 2006·Granted Jul 20, 2010·57 cites·9 claims
- 0294US8088931B2Small molecule inhibitors of MDM2 and the uses thereofWANG SHAOMENG·Filed 2010·Granted Jan 3, 2012·28 cites·8 claims
- 0392US9617272B2Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolizationNEWLINK GENETICS CORP·Filed 2014·Granted Apr 11, 2017·21 cites·43 claims
- 0490US9260434B2Fused imidazole derivatives useful as IDO inhibitorsNEWLINK GENETICS CORP·Filed 2013·Granted Feb 16, 2016·11 cites·29 claims
- 0589US10233190B2IDO inhibitorsNEWLINK GENETICS CORP·Filed 2017·Granted Mar 19, 2019·6 cites·20 claims
- 0688US7683068B2Hydroisoindoline tachykinin receptor antagonistsMERCK SHARP & DOHME·Filed 2006·Granted Mar 23, 2010·18 cites·9 claims
- 0787US9388191B2Fused imidazole derivatives useful as IDO inhibitorsNEWLINK GENETICS CORP·Filed 2015·Granted Jul 12, 2016·5 cites·26 claims
- 0887US8518984B2Spiro-oxindole MDM2 antagonistsWANG SHAOMENG·Filed 2010·Granted Aug 27, 2013·11 cites·37 claims
- 0986US9732035B2Salts and prodrugs of 1-methyl-D-tryptophanNEWLINK GENETICS CORP·Filed 2016·Granted Aug 15, 2017·5 cites·30 claims
- 1081US8901117B2Small molecule inhibitors of MDM2 and the uses thereofWANG SHAOMENG·Filed 2011·Granted Dec 2, 2014·2 cites·7 claims
- 1181US8748469B2IDO inhibitorsMAUTINO MARIO R·Filed 2009·Granted Jun 10, 2014·6 cites·7 claims
- 1280US10800780B2TDO2 InhibitorsGENENTECH INC·Filed 2016·Granted Oct 13, 2020·4 cites·17 claims
- 1380US9079913B2Spiro-oxindole MDM2 antagonistsUNIV MICHIGAN·Filed 2014·Granted Jul 14, 2015·3 cites·15 claims
- 1475US10207990B2Salts and prodrugs of 1-methyl-D-tryptophanNEWLINK GENETICS CORP·Filed 2017·Granted Feb 19, 2019·1 cites·27 claims
- 1575US8877796B2Spiro-oxindole MDM2 antagonistsUNIV MACHIGAN·Filed 2013·Granted Nov 4, 2014·4 cites·23 claims
- 1674US9850248B2IDO inhibitorsNEWLINK GENETICS CORP·Filed 2016·Granted Dec 26, 2017·1 cites·36 claims
- 1774US9174942B2IDO inhibitorsNEWLINK GENETICS CORP·Filed 2014·Granted Nov 3, 2015·2 cites·19 claims
- 1873US8722720B2Imidazole derivatives as IDO inhibitorsMAUTINO MARIO R·Filed 2010·Granted May 13, 2014·2 cites·15 claims
- 1972US11827639B2TDO2 and IDO1 inhibitorsGENENTECH INC·Filed 2018·Granted Nov 28, 2023·1 cites·14 claims
- 2072US9981973B2Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolizationNEWLINK GENETICS CORP·Filed 2017·Granted May 29, 2018·1 cites·38 claims
- 2170US2024132507A1TDO2 and IDO1 InhibitorsGENENTECH INC·Filed 2023·Application pending·0 cites
- 2269US11485705B2Salts and prodrugs of 1-methyl-d-tryptophanLUMOS PHARMA INC·Filed 2020·Granted Nov 1, 2022·0 cites·20 claims
- 2364US7348456B2Substituted amidesMERCK & CO INC·Filed 2003·Granted Mar 25, 2008·2 cites·13 claims
- 2464US2024190868A1Sos1 inhibitorsACERAND THERAPEUTICS USA LTD·Filed 2023·Application pending·0 cites
- 2560US2019248739A1Salts and prodrugs of 1-methyl-d-tryptophanNEWLINK GENETICS CORP·Filed 2019·Application pending·0 cites
- 2657US2019225618A1IDO InhibitorsMAUTINO MARIO·Filed 2019·Application pending·0 cites
- 2756US7576239B2Substituted amidesMERCK & CO INC·Filed 2008·Granted Aug 18, 2009·0 cites·12 claims
- 2855US10889549B2Continuous process for the preparation of 2-(1H-imidazol-4-yl) ethanamine and pharmaceutically acceptable salts thereofJUBILANT GENERICS LTD·Filed 2020·Granted Jan 12, 2021·0 cites·20 claims
- 2955US2024050541A1Intra-renal infusions of c1 inhibitor prior to transplantation of allografts to reduce delayed graft function and ischemia/reperfusion injury and to improve long-term graft functionCEDARS SINAI MEDICAL CENTER·Filed 2021·Application pending·0 cites
- 3053US2022324862A1Pyridopyrimidinone compoundsACERAND THERAPEUTICS USA LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sanjeev Kumar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →